Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.

Benowitz NL, Nardone N, Dains KM, Hall SM, Stewart S, Dempsey D, Jacob P 3rd.

Addiction. 2015 Oct;110(10):1667-75. doi: 10.1111/add.12978. Epub 2015 Jul 21.

2.

Nicotine and carcinogen exposure after water pipe smoking in hookah bars.

St Helen G, Benowitz NL, Dains KM, Havel C, Peng M, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1055-66. doi: 10.1158/1055-9965.EPI-13-0939. Epub 2014 May 16.

3.

Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes.

Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):761-9. doi: 10.1158/1055-9965.EPI-11-0644. Epub 2012 Feb 21.

4.

Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.

Benowitz NL, Dains KM, Dempsey D, Wilson M, Jacob P.

Nicotine Tob Res. 2011 Sep;13(9):772-83. doi: 10.1093/ntr/ntr072. Epub 2011 May 5.

5.

Urine menthol as a biomarker of mentholated cigarette smoking.

Benowitz NL, Dains KM, Dempsey D, Havel C, Wilson M, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3013-9. doi: 10.1158/1055-9965.EPI-10-0706. Epub 2010 Oct 20.

6.

Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.

Benowitz NL, Dains KM, Dempsey D, Yu L, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1160-6. doi: 10.1158/1055-9965.EPI-09-1303.

7.

Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening.

Benowitz NL, Schultz KE, Haller CA, Wu AH, Dains KM, Jacob P 3rd.

Am J Epidemiol. 2009 Oct 1;170(7):885-91. doi: 10.1093/aje/kwp215. Epub 2009 Aug 27.

8.

Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure.

Benowitz NL, Dains KM, Dempsey D, Herrera B, Yu L, Jacob P 3rd.

Nicotine Tob Res. 2009 Aug;11(8):954-60. doi: 10.1093/ntr/ntp092. Epub 2009 Jun 12.

9.

Progressive commercial cigarette yield reduction: biochemical exposure and behavioral assessment.

Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):876-83. doi: 10.1158/1055-9965.EPI-08-0731. Epub 2009 Mar 3.

10.

Positional cloning of the combined hyperlipidemia gene Hyplip1.

Bodnar JS, Chatterjee A, Castellani LW, Ross DA, Ohmen J, Cavalcoli J, Wu C, Dains KM, Catanese J, Chu M, Sheth SS, Charugundla K, Demant P, West DB, de Jong P, Lusis AJ.

Nat Genet. 2002 Jan;30(1):110-6. Epub 2001 Dec 20.

11.

Genome-tagged mice (GTM): two sets of genome-wide congenic strains.

Iakoubova OA, Olsson CL, Dains KM, Ross DA, Andalibi A, Lau K, Choi J, Kalcheva I, Cunanan M, Louie J, Nimon V, Machrus M, Bentley LG, Beauheim C, Silvey S, Cavalcoli J, Lusis AJ, West DB.

Genomics. 2001 May 15;74(1):89-104.

PMID:
11374905
12.

Microsatellite marker panels for use in high-throughput genotyping of mouse crosses.

Iakoubova OA, Olsson CL, Dains KM, Choi J, Kalcheva I, Bentley LG, Cunanan M, Hillman D, Louie J, Machrus M, West DB.

Physiol Genomics. 2000 Sep 8;3(3):145-8.

PMID:
11015609

Supplemental Content

Loading ...
Support Center